Anti-GFRA2/ GDNFRB/ NRTNR-ALPHA monoclonal antibody

Anti-GFRA2/ GDNFRB/ NRTNR-ALPHA antibody for FACS & in-vivo assay

Target products collectionGo to GFRA2/GFRA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0479-Ab-1/ GM-Tg-hg-MP0479-Ab-2Anti-Human GFRA2 monoclonal antibodyHuman
GM-Tg-rg-MP0479-Ab-1/ GM-Tg-rg-MP0479-Ab-2Anti-Rat GFRA2 monoclonal antibodyRat
GM-Tg-mg-MP0479-Ab-1/ GM-Tg-mg-MP0479-Ab-2Anti-Mouse GFRA2 monoclonal antibodyMouse
GM-Tg-cynog-MP0479-Ab-1/ GM-Tg-cynog-MP0479-Ab-2Anti-Cynomolgus/ Rhesus macaque GFRA2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0479-Ab-1/ GM-Tg-felg-MP0479-Ab-2Anti-Feline GFRA2 monoclonal antibodyFeline
GM-Tg-cang-MP0479-Ab-1/ GM-Tg-cang-MP0479-Ab-2Anti-Canine GFRA2 monoclonal antibodyCanine
GM-Tg-bovg-MP0479-Ab-1/ GM-Tg-bovg-MP0479-Ab-2Anti-Bovine GFRA2 monoclonal antibodyBovine
GM-Tg-equg-MP0479-Ab-1/ GM-Tg-equg-MP0479-Ab-2Anti-Equine GFRA2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0479-Ab-1/ GM-Tg-hg-MP0479-Ab-2; GM-Tg-rg-MP0479-Ab-1/ GM-Tg-rg-MP0479-Ab-2;
GM-Tg-mg-MP0479-Ab-1/ GM-Tg-mg-MP0479-Ab-2; GM-Tg-cynog-MP0479-Ab-1/ GM-Tg-cynog-MP0479-Ab-2;
GM-Tg-felg-MP0479-Ab-1/ GM-Tg-felg-MP0479-Ab-2; GM-Tg-cang-MP0479-Ab-1/ GM-Tg-cang-MP0479-Ab-2;
GM-Tg-bovg-MP0479-Ab-1/ GM-Tg-bovg-MP0479-Ab-2; GM-Tg-equg-MP0479-Ab-1/ GM-Tg-equg-MP0479-Ab-2
Products NameAnti-GFRA2 monoclonal antibody
Formatmab
Target NameGFRA2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GFRA2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GFRA2/ GDNFRB/ NRTNR-ALPHA VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0479-Ag-1GDNF family receptor alpha 2 (GFRA2) protein
    ORF Viral VectorpGMLP002235human GFRA2 Lentivirus plasmid
    ORF Viral VectorvGMLP002235human GFRA2 Lentivirus particle


    Target information

    Target IDGM-MP0479
    Target NameGFRA2
    Gene ID2675,14586,25136,715110,609172,101091865,514036,100146260
    Gene Symbol and SynonymsGDNFRB,GFRA2,NRTNR-ALPHA,NTNRA,RETL2,TRNR2
    Uniprot AccessionO00451,Q5E9X0
    Uniprot Entry NameGFRA2_HUMAN,GFRA2_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000168546
    Target ClassificationN/A

    The target: GFRA2, gene name: GFRA2, also named as GDNFRB, NRTNR-ALPHA, NTNRA, RETL2, TRNR2. Glial cell line-derived neurotrophic factor (GDNF) and neurturin (NTN) are two structurally related, potent neurotrophic factors that play key roles in the control of neuron survival and differentiation. The protein encoded by this gene is a member of the GDNF receptor family. It is a glycosylphosphatidylinositol(GPI)-linked cell surface receptor for both GDNF and NTN, and mediates activation of the RET tyrosine kinase receptor. This encoded protein acts preferentially as a receptor for NTN compared to its other family member, GDNF family receptor alpha 1. This gene is a candidate gene for RET-associated diseases. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.